Design, synthesis, biological screening, and molecular docking studies of piperazine-derived constrained inhibitors of DPP-IV for the treatment of type 2 diabetes. [electronic resource]
Producer: 20151201Description: 439-46 p. digitalISSN:- 1747-0285
- Animals
- Blood Glucose -- metabolism
- Diabetes Mellitus, Type 2 -- drug therapy
- Dipeptidyl Peptidase 4 -- metabolism
- Dipeptidyl-Peptidase IV Inhibitors -- chemical synthesis
- Humans
- Hypoglycemic Agents -- chemical synthesis
- Mice
- Molecular Docking Simulation
- Piperazine
- Piperazines -- chemical synthesis
- Pyrrolidines -- chemical synthesis
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.